J. Skipper

发表

Fast association rates suggest a conformational change in the MHC class I molecule H-2Db upon peptide binding.

V. Cerundolo, A. Townsend, S. Springer, 1998, Biochemistry.

Mass‐spectrometric evaluation of HLA‐A*0201‐associated peptides identifies dominant naturally processed forms of CTL epitopes from MART‐1 and gp100

J. Shabanowitz, D. Hunt, V. Engelhard, 1999 .

Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100.

D. Hunt, V. Engelhard, C. Slingluff, 1996, Journal of immunology.

Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras protein

H. Stauss, J. Skipper, 1993, The Journal of experimental medicine.

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

R. Henderson, J. Shabanowitz, D. Hunt, 1994, Science.

Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens

D. Hunt, V. Engelhard, C. Slingluff, 2000, Cancer Immunology, Immunotherapy.

Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development.

J. Shabanowitz, D. Hunt, V. Engelhard, 1998, Journal of immunology.

An HLA-A2 restricted tyrosinase epitope on melanoma cells results from post-translational modification

J. Shabanowitz, D. Hunt, V. Engelhard, 1995 .

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

J. Shabanowitz, D. Hunt, V. Engelhard, 1996, The Journal of experimental medicine.

Cryptic CTL Epitope on a Murine Sarcoma Meth A Generated by Exon Extension as a Novel Mechanism1

T. Ono, E. Nakayama, S. Win, 2003, The Journal of Immunology.

Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.

D. Jäger, Yao-Tseng Chen, J. Karbach, 2002, Cancer immunity.

Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100.

J. Shabanowitz, D. Hunt, V. Engelhard, 1999, International journal of cancer.

Identification of a graft versus host disease-associated human minor histocompatibility antigen.

F Koning, J. Shabanowitz, D. Hunt, 1995, Science.

HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones.

D. Jäger, Yao-Tseng Chen, J. Karbach, 2004, Cancer immunity.

HLA-DP 4 expression and immunity to NY-ESO-1 : correlation and characterization of cytotoxic CD 4 + CD 25-CD 8-T cell clones

D. Jäger, Yao-Tseng Chen, J. Karbach, 2004 .

The Immunodominant Antigen of an Ultraviolet-induced Regressor Tumor Is Generated by a Somatic Point Mutation in the DEAD Box Helicase p68

J. Shabanowitz, D. Hunt, V. Engelhard, 1997, The Journal of experimental medicine.

A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.

K. Odunsi, L. Old, D. Driscoll, 2005, Gynecologic Oncology.

Chemotherapy of advanced ovarian adenocarcinoma: a randomized comparison of combination versus sequential therapy using chlorambucil and cisplatin.

A. Coates, J. Campbell, C. Sutherland, 1986, Gynecologic oncology.

Immunization of ovarian cancer patients with an NY-ESO-1 peptide of dual MHC class I and II specificities plus incomplete Freund adjuvant induces simultaneous humoral, CD4+ and CD8+ T-cell responses

K. Odunsi, L. Old, S. Gnjatic, 2005 .

TPTE "Cancer/Testis" antigen is a candidate target for immunotherapy in epithelial ovarian carcinoma

A. Simpson, K. Odunsi, L. Old, 2005 .